Anthelmintic activity of seaweed extract of Padina boergesenii and Padina tetrastromatica acute subacute level in naturally infected sheep

Background: Seaweeds have showed a broad range of biological activities such as antiviral, cardiovascular, autoimmune diseases, antineoplastic antibacterial, anti-inflammatory, and antifungal activities. Aims and Objectives: This study was done to assess capability of Padina boergesenii and Padina tetrastromatica extract for anthelmintic activity in sheep agonized with clinical parasitic gastroenteritis in different concentrations and compared it against the standard drug albendazole using natural acute/subacute parasitic gastroenteritis due primarily to mixed nematode species. Materials and Methods: The anthelmintic activity of ethanolic extract of seaweed of P. boergesenii was studied in sheep with natural acute/subacute parasitic gastroenteritis due primarily to mixed nematode species. Graded doses of the extract (100, 200, and 300 mg/kg, p.o for 5 consecutive days) significantly reduced fecal egg counts in infected animals. The percentage reduction (96.1%) by 300 mg/kg of the extract was comparable to that of 5 mg/kg of albendazole (94.3%). Results: The administration of the extract resulted in improved hemoglobin and leukocytosis values in worm infected sheep. Conclusion: The current study evidence that the anthelmintic activity of the ethanolic extract of seaweed of P. boergesenii and P. tetrastromatica has promising anthelmintic activity against strongyle, Strongyloides papillosus, and Taenia ovis. However, the anthelmintic activity of P. boergesenii was superior to P. tetrastromatica.

Correlation of risk factors with Glasgow coma scale to predict the severity and outcome of children with non-traumatic coma

Background: Non-traumatic coma is the problem of pediatric group, accounts 10-15% in hospital admissions. Assessment of the severity of coma is useful to speculate the survival. The aim was to assess outcome in pediatric non-traumatic coma with role of Glasgow coma scale and modified Glasgow coma scale.Methods: Total of 80 cases of non-traumatic coma between 1 month to 12 years, coma severity was assessed by using Glasgow coma scale. A score of less than 8 and more than 8 were used for analysis of outcome.Results: The maximum number of patents with non-traumatic coma were in the age group of 1 month-5 years, 40 children (50%). On neurological examination 42 (52.5%) children has GCS score of >8, 38 cases (47.5%) has GCS <8, 20 children had meningeal signs, 7 children had cranial nerve deficit (7th nerve), 9 children had decebrate posture. Out of 80 cases, 8 cases expired (10%), 4 cases were discharged against medical advice (4%), 68 cases were improved and discharged (85%), among these, 8 cases were discharged with complication (11.7%). Overall mortality was (10%) (8/80), males outnumbered females in frequency with ratio of 1.28:1. CNS infection accounted for almost about 66%.Conclusions: Children with GCS and MGCS scores of less than 8 have poor prognosis and a very high probability of death. Those with GCS score of more than 8 have good prognosis. Identification of these cases at the outset can help prepare the treating physician to plan critical care referral and to give a preliminary assessment of outcome to the family.